Related Experiment Videos
Respiratory syncytial virus--viral biology and the host response
1International Child Health Group, Department of Paediatrics, University of Oxford, John Radcliffe Hospital, Headington, Oxford OX3 9DU, UK. doug.hacking@imm.ox.ac.uk
Insights
Respiratory syncytial virus (RSV) causes severe infant respiratory infections. Host genetic variations may influence disease severity, highlighting potential targets for new therapies and vaccines.
Area of Science:
- Pediatric infectious diseases
- Virology
- Immunology
Background:
- Respiratory syncytial virus (RSV) is a leading cause of infant respiratory illness.
- The factors determining RSV disease severity in infants are not fully understood.
- Current treatments for RSV infection are limited, with no effective antiviral options.
Purpose of the Study:
- To explore the biological underpinnings of RSV infection severity in infants.
- To identify potential targets for novel antiviral therapies and vaccine development.
- To investigate the role of host immune responses in RSV-induced bronchiolitis.
Main Methods:
- Analysis of RSV biology, focusing on attachment (G) and fusion (F) proteins.
- Investigation of the inflammatory response mediated by airway epithelial cells.
- Evaluation of cell-mediated and humoral immune responses in RSV infection.
- Examination of host genetic variations and their impact on RSV outcomes.
Main Results:
- Advances in understanding RSV G and F proteins offer therapeutic and vaccine targets.
- RSV infection triggers an intense inflammatory response initiated by airway epithelial cells.
- Cell-mediated immunity is crucial for infection control and viral clearance.
- Humoral immunity plays a significant role in protection against RSV.
- Early evidence suggests host genetic variations influence the severity of RSV-induced bronchiolitis.
Conclusions:
- Understanding RSV G and F proteins is key to developing new treatments and vaccines.
- The host immune response, including genetic factors, significantly impacts RSV disease progression.
- Further research into host-pathogen interactions is needed to combat RSV effectively in infants.
Abstract:
Respiratory syncytial virus (RSV) is the most important cause of respiratory tract infection in infants. We have an incomplete understanding of the reasons why some infants are more severely affected by RSV than others. There is no effective antiviral treatment for the infection. Advances in our understanding of the biology of RSV, particularly in relation to the attachment protein G and the fusion protein F, have revealed potential targets for new antiviral therapies and vaccine development. In response to RSV infection an intense inflammatory response is triggered, mediated initially by the infected airway epithelial cells. Cell mediated responses are important in controlling the extent of infection and in viral clearance. Humoral responses are important in protection. There is early evidence that genetic variation of the host response can influence the outcome of RSV-induced bronchiolitis.